Health System

Real-world Evidence Details Use of Ixazomib as Maintenance Therapy for MM

December 1st 2021, 5:25pm


Results of a retrospective study conducted in China assessed the safety and efficacy of ixazomib for multiple myeloma.

Rituximab Infusion Timing, Dosing and COVID-19 Hospitalization Not Linked, Study Says

December 1st 2021, 4:00pm


A study examining the relation between rituximab infusion and hospitalization as a result of COVID-19 for patients with multiple sclerosis (MS) found that the 2 were not related, contradicting past research.

Increasing Trust in Health Care

December 1st 2021, 2:00pm


This commentary describes 4 dimensions of trust that have been illuminated by contributions from leading health care organizations to the ABIM Foundation’s Trust Practices Network.

Millennials With Multiple Sclerosis: Are They Different or Has Medicine Evolved?

November 30th 2021, 9:00pm


On this episode of Managed Care Cast, hear from a multiple sclerosis (MS) specialist about how millennial patients are different (or not) in how they approach their disease.

Mobile App Shows Promise as Obstructive Sleep Apnea Risk Assessment Tool

November 30th 2021, 6:55pm


A mobile app was shown to be feasible in identifying risk of obstructive sleep apnea and associated symptoms, as well as promoting management recommendations among an outpatient cohort.

What We're Reading: Booster Shots for All Adults; Vaccine Mandates Suspended; Previewing Landmark Abortion Case

November 30th 2021, 3:47pm


The CDC expands its recommendation on booster shots to all adults aged 18 and older amid Omicron variant concerns; a federal judge temporarily blocks COVID-19 vaccine mandates for health workers in 10 states; the Supreme Court will begin hearing arguments on Mississippi’s landmark abortion case tomorrow.

What We're Reading: Omicron Variant Response; Lung Transplants for Patients With COVID-19; Panel to Review Merck’s COVID-19 Pill

November 29th 2021, 3:30pm


President Joe Biden will provide an update today on his administration’s response to the Omicron COVID-19 variant; marked rise in lung transplants for patients with COVID-19 sparks ethical questions; an independent panel of experts will advise FDA tomorrow on the use of Merck’s COVID-19 antiviral pill.

Kimberly Westrich on Incentivizing Value-Based Care in Benefit Design and Reimbursement Strategies

November 28th 2021, 2:00pm


Kimberly Westrich, MA, vice president of health services research at the National Pharmaceutical Council, discusses the shift to a value-based system from a fee-for-service one and how the health care system can incentivize high-value care.

Dr Robert Hopkin Addresses HRQOL Factors in Fabry Disease

November 26th 2021, 2:00pm


Robert J. Hopkin, MD, clinical geneticist, Cincinnati Children's Hospital Medical Center, details various known and understudied health-related quality-of-life factors in patients with Fabry disease.

Contributor: Equity, Not Equality, Is Needed to Close Racial Gap in Chronic Kidney Disease Outcomes

November 24th 2021, 4:00pm


Improving clinical care is only one element of the 360-degree, holistic treatment that is necessary to achieve patient equity, not equality, in patients with chronic kidney disease. Biology, lifestyle, and socioeconomic status are 3 areas in which inequities often have a particularly negative impact on a carefully constructed care plan.